Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2004;90:977-979; doi:10.1136/hrt.2003.012997
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2004;90:977-979
© 2004 by BMJ Publishing Group & British Cardiac Society

EDITORIAL

Anaemia and heart failure

A J S Coats

Correspondence to:
Correspondence to:
Professor Andrew J S Coats
Faculty of Medicine, University of Sydney, Sydney, NSW 2006, Australia; ajscoats@med.usyd.edu.au


Anaemia has been found to be a common complication of chronic heart failure, reducing oxygen delivery to the periphery. Erythropoietin to correct anaemia has a long history in the management of renal failure with complicating anaemia, and the first reports of the use or erythropoietin in heart failure are coming through.

Abbreviations: ACE, angiotensin converting enzyme; CHF, chronic heart failure; CRF, chronic renal failure; EPO, erythropoietin; GFR, glomerular filtration rate; PKV·O2, peak oxygen consumption; SOLVD, studies of left ventricular dysfunction; TNF{alpha}, tumour necrosis factor {alpha}

Keywords: heart failure; symptoms; pathophysiology; anaemia; erythropoietin; exercise tolerance

The first 150 words of the full text of this article appear below.

Chronic heart failure (CHF) is frequently associated with poor exercise tolerance and debilitating symptoms despite optimal modern treatment. In the past we expected that this was due to the direct consequences of poor cardiac output and congested lungs. Other important pathophysiological disturbances in CHF occur as both short and long term consequences of the initial cardiac dysfunction. These include neurohormonal activation, cytokine release and trophic changes in skeletal muscle and the peripheral vasculature, and disturbances in reflex control systems.

The severity of symptomatic exercise limitation varies between patients, and bears little relation to the extent of the left ventricular systolic dysfunction measured at rest, or to markers of central haemodynamic disturbance.1 Although there are several reasons for this, much recent research has suggested that changes which occur in the periphery as a consequence of the systemic effects of heart failure, may have become the principal factors limiting exercise.2 Many changes . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Cheng, T. O. (2005). Is There an Optimal Hematocrit Value for Cardiac Patients?. J Am Coll Cardiol 45: 1549-1549 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.